資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/34323
|
| 標題: | 8-Hydroxydaidzein Downregulates JAK/STAT, MMP, Oxidative Phosphorylation, and PI3K/AKT Pathways in K562 Cells |
| 作者: | Wu, Pei-Shan
Wang, Chih-Yang
Chen, Pin-Shern
Hung, Jui-Hsiang
Yen, Jui-Hung
Wu, Ming-Jiuan |
| 貢獻者: | Chia Nan Univ Pharm & Sci, Dept Appl Life Sci & Hlth
Taipei Med Univ, Ph Program Canc Mol Biol & Drug Discovery
Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery
Chia Nan Univ Pharm & Sci, Dept Biotechnol
Tzu Chi Univ, Dept Mol Biol & Human Genet
Tzu Chi Univ, Inst Med Sci |
| 關鍵字: | K562
8-hydroxydaidzein
JAK
STAT
MMP
OXPHOS
AKT |
| 日期: | 2021 |
| 上傳時間: | 2023-11-11 11:43:32 (UTC+8) |
| 出版者: | MDPI |
| 摘要: | A metabolite isolated from fermented soybean, 8-hydroxydaidzein (8-OHD, 7,8,4 '-trihydroxyisoflavone, NSC-678112), is widely used in ethnopharmacological research due to its anti-proliferative and anti-inflammatory effects. We reported previously that 8-OHD provoked reactive oxygen species (ROS) overproduction, and induced autophagy, apoptosis, breakpoint cluster region-Abelson murine leukemia viral oncogene (BCR-ABL) degradation, and differentiation in K562 human chronic myeloid leukemia (CML) cells. However, how 8-OHD regulates metabolism, the extracellular matrix during invasion and metastasis, and survival signaling pathways in CML remains largely unexplored. High-throughput technologies have been widely used to discover the therapeutic targets and pathways of drugs. Bioinformatics analysis of 8-OHD-downregulated differentially expressed genes (DEGs) revealed that Janus kinase/signal transducer and activator of transcription (JAK/STAT), matrix metalloproteinases (MMPs), c-Myc, phosphoinositide 3-kinase (PI3K)/AKT, and oxidative phosphorylation (OXPHOS) metabolic pathways were significantly altered by 8-OHD treatment. Western blot analyses validated that 8-OHD significantly downregulated cytosolic JAK2 and the expression and phosphorylation of STAT3 dose- and time-dependently in K562 cells. Zymography and transwell assays also confirmed that K562-secreted MMP9 and invasion activities were dose-dependently inhibited by 8-OHD after 24 h of treatment. RT-qPCR analyses verified that 8-OHD repressed metastasis and OXPHOS-related genes. In combination with DisGeNET, it was found that 8-OHD's downregulation of PI3K/AKT is crucial for controlling CML development. A STRING protein-protein interaction analysis further revealed that AKT and MYC are hub proteins for cancer progression. Western blotting revealed that AKT phosphorylation and nuclear MYC expression were significantly inhibited by 8-OHD. Collectively, this systematic investigation revealed that 8-OHD exerts anti-CML effects by downregulating JAK/STAT, PI3K/AKT, MMP, and OXPHOS pathways, and MYC expression. These results could shed new light on the development of 8-OHD for CML therapy. |
| 關聯: | BIOMEDICINES, v.9, n.12, pp.1907 |
| 顯示於類別: | [生活保健科技系] 期刊論文
[生物科技系(所)] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| biomedicines9121907.pdf | | 12893Kb | Adobe PDF | 132 | 檢視/開啟 | | index.html | | 0Kb | HTML | 283 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
